|
|
||||||||
Department of Pharmacology, University of Bath, Bath, United Kingdom; and Bath Institute for Rheumatic Diseases, Bath, United Kingdom
Although the role of CD28 in T cell costimulation is firmly
established, the mechanisms by which it exerts its costimulatory
actions are less clear. In many circumstances it is difficult to
distinguish the effects of CD28 from subsequent actions of cytokines,
such as IL-2, on T cell proliferation. Here, we report a model of CD28
costimulation using PMA plus the natural ligand CD80 that resulted in
very limited stimulation of IL-2, as evidenced by both cytokine
production and IL-2 promoter stimulation. Promoter assays revealed
CD28-dependent effects on both NF-
B and AP-1, but not on NF-AT or
the intact IL-2 promoter. In addition, T cell proliferation was
completely resistant to the actions of the immunosuppressant
cyclosporin A (CsA). Moreover T cell proliferation was unaffected by
the addition of blocking Abs to both IL-2 and the IL-2 receptor,
demonstrating that this form of costimulation by CD28 was independent
of IL-2. We also investigated the effects of stimulating T cell blasts
with CD80 alone and found that there was a limited requirement for IL-2
in this system. We conclude that CD28 costimulation can cause
substantial T cell proliferation in the absence of IL-2, which is
driven by a soluble factor independent of NF-AT
transactivation.
This article has been cited by other articles:
![]() |
C. Scotta, M. Soligo, C. Camperio, and E. Piccolella FOXP3 Induced by CD28/B7 Interaction Regulates CD25 and Anergic Phenotype in Human CD4+CD25- T Lymphocytes J. Immunol., July 15, 2008; 181(2): 1025 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kerstan, N. Armbruster, M. Leverkus, and T. Hunig Cyclosporin A Abolishes CD28-Mediated Resistance to CD95-Induced Apoptosis via Superinduction of Caspase-3 J. Immunol., December 1, 2006; 177(11): 7689 - 7697. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wittmann, C. Killig, M. Bruder, R. Gutzmer, and T. Werfel Critical involvement of IL-12 in IFN-{gamma} induction by calcineurin antagonists in activated human lymphocytes J. Leukoc. Biol., July 1, 2006; 80(1): 75 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Colombetti, V. Basso, D. L. Mueller, and A. Mondino Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of Rapamycin. J. Immunol., March 1, 2006; 176(5): 2730 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canto, J. L. Rodriguez-Sanchez, and S. Vidal Distinctive response of naive lymphocytes from cord blood to primary activation via TCR J. Leukoc. Biol., December 1, 2003; 74(6): 998 - 1007. [Abstract] [Full Text] |
||||
![]() |
R. Bommireddy, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, and T. Doetschman TGF{beta}1 Inhibits Ca2+-Calcineurin-Mediated Activation in Thymocytes J. Immunol., April 1, 2003; 170(7): 3645 - 3652. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Colombetti, F. Benigni, V. Basso, and A. Mondino Clonal Anergy Is Maintained Independently of T Cell Proliferation J. Immunol., December 1, 2002; 169(11): 6178 - 6186. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. S. Kum, S. B. Cameron, R. W. Y. Hung, S. Kalyan, and A. W. Chow Temporal Sequence and Kinetics of Proinflammatory and Anti-Inflammatory Cytokine Secretion Induced by Toxic Shock Syndrome Toxin 1 in Human Peripheral Blood Mononuclear Cells Infect. Immun., December 1, 2001; 69(12): 7544 - 7549. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Han, S. H. Park, Y. J. Jeon, Y. K. Kim, H. M. Kim, and K. H. Yang Prodigiosin Blocks T Cell Activation by Inhibiting Interleukin-2Ralpha Expression and Delays Progression of Autoimmune Diabetes and Collagen-Induced Arthritis J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Kapsogeorgou, H. M. Moutsopoulos, and M. N. Manoussakis Functional Expression of a Costimulatory B7.2 (CD86) Protein on Human Salivary Gland Epithelial Cells that Interacts with the CD28 Receptor, but Has Reduced Binding to CTLA4 J. Immunol., March 1, 2001; 166(5): 3107 - 3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Malek, A. Yu, P. Scibelli, M. G. Lichtenheld, and E. K. Codias Broad Programming by IL-2 Receptor Signaling for Extended Growth to Multiple Cytokines and Functional Maturation of Antigen-Activated T Cells J. Immunol., February 1, 2001; 166(3): 1675 - 1683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |